Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2016

01-06-2016 | Epidemiology

Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer

Authors: Jinhai Huo, Benjamin D. Smith, Sharon H. Giordano, Gregory P. Reece, Ya-Chen Tina Shih

Published in: Breast Cancer Research and Treatment | Issue 2/2016

Login to get access

Abstract

To compare the utilization pattern of breast reconstruction between obese and non-obese patients and assess the association between obesity and postoperative complications as well as healthcare costs. Using MarketScan databases, we identified 2558 breast cancer patients who underwent mastectomy between 2009 and 2012. Temporal trends in breast reconstruction were assessed using the Cochran–Armitage test. Logistic regression models were performed to determine the association between obesity and the occurrence of postoperative complications. Healthcare costs were compared using a generalized linear model. Among 2558 patients treated with mastectomy, the breast reconstruction rate of non-obese patients (76.2 %) was significantly higher than patients in obese class I and class II&III (63.3 and 60.2 %, respectively; P < 0.001). Compared with non-obese patients, obese patients had significantly higher rates of infection (OR 1.53, for obese class I, and OR 1.60, for obese class II&III, both P < 0.01), wound (OR 1.51, P = 0.01 for obese class I, and OR 1.98, P < 0.001 for obese class II&III), and perfusion complications (OR 1.73, P = 0.01 for obese class I, and OR 2.21, P < 0.01 for obese class II&III). The mean postoperative complication cost for non-obese patients ($4684) was significantly lower than those for obese class I patients ($6250) and obese class II&III patients ($7868; P < 0.001). Our analysis demonstrated a significant gap in breast reconstruction between obese and non-obese patients, and our finding underscores the need for careful preoperative assessment of obese patients and call for additional research to minimize the risk of complications.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham L, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russell I (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312(11):665–673. doi:10.1056/NEJM198503143121101 CrossRefPubMed Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham L, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russell I (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312(11):665–673. doi:10.​1056/​NEJM198503143121​101 CrossRefPubMed
3.
go back to reference 2014 Breast Cancer Standards Manual (2014). American College of Surgeons, Chicago, IL 2014 Breast Cancer Standards Manual (2014). American College of Surgeons, Chicago, IL
5.
go back to reference Mahmood U, Hanlon A, Koshy M, Buras R, Chumsri S, Tkaczuk K, Cheston S, Regine W, Feigenberg S (2013) Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 20(5):1436–1443. doi:10.1245/s10434-012-2732-5 CrossRefPubMed Mahmood U, Hanlon A, Koshy M, Buras R, Chumsri S, Tkaczuk K, Cheston S, Regine W, Feigenberg S (2013) Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 20(5):1436–1443. doi:10.​1245/​s10434-012-2732-5 CrossRefPubMed
7.
go back to reference Frost MH, Slezak JM, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23(31):7849–7856. doi:10.1200/jco.2005.09.233 CrossRefPubMed Frost MH, Slezak JM, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23(31):7849–7856. doi:10.​1200/​jco.​2005.​09.​233 CrossRefPubMed
8.
go back to reference Ueda S, Tamaki Y, Yano K, Okishiro N, Yanagisawa T, Imasato M, Shimazu K, Kim SJ, Miyoshi Y, Tanji Y, Taguchi T, Noguchi S (2008) Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast. Surgery 143(3):414–425. doi:10.1016/j.surg.2007.10.006 CrossRefPubMed Ueda S, Tamaki Y, Yano K, Okishiro N, Yanagisawa T, Imasato M, Shimazu K, Kim SJ, Miyoshi Y, Tanji Y, Taguchi T, Noguchi S (2008) Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast. Surgery 143(3):414–425. doi:10.​1016/​j.​surg.​2007.​10.​006 CrossRefPubMed
11.
13.
go back to reference Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Kronowitz SJ, Smith BD (2014) Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. doi:10.1200/jco.2013.52.2284 Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Kronowitz SJ, Smith BD (2014) Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. doi:10.​1200/​jco.​2013.​52.​2284
15.
go back to reference Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Wang E, Kim JYS (2013) Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 216(2):229–238. doi:10.1016/j.jamcollsurg.2012.11.003 CrossRefPubMed Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Wang E, Kim JYS (2013) Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 216(2):229–238. doi:10.​1016/​j.​jamcollsurg.​2012.​11.​003 CrossRefPubMed
17.
go back to reference Fischer JP, Nelson JA, Serletti JM, Wu LC (2013) Peri-operative risk factors associated with early tissue expander (TE) loss following immediate breast reconstruction (IBR): A review of 9305 patients from the 2005–2010 ACS-NSQIP datasets. J Plast Reconstr Aesthet Surg 66(11):1504–1512. doi:10.1016/j.bjps.2013.06.030 CrossRefPubMed Fischer JP, Nelson JA, Serletti JM, Wu LC (2013) Peri-operative risk factors associated with early tissue expander (TE) loss following immediate breast reconstruction (IBR): A review of 9305 patients from the 2005–2010 ACS-NSQIP datasets. J Plast Reconstr Aesthet Surg 66(11):1504–1512. doi:10.​1016/​j.​bjps.​2013.​06.​030 CrossRefPubMed
19.
20.
go back to reference Brooke S, Mesa J, Uluer M, Michelotti B, Moyer K, Neves RI, Mackay D, Potochny J (2012) Complications in tissue expander breast reconstruction: a comparison of AlloDerm, DermaMatrix, and FlexHD acellular inferior pole dermal slings. Ann Plast Surg 69(4):347CrossRefPubMed Brooke S, Mesa J, Uluer M, Michelotti B, Moyer K, Neves RI, Mackay D, Potochny J (2012) Complications in tissue expander breast reconstruction: a comparison of AlloDerm, DermaMatrix, and FlexHD acellular inferior pole dermal slings. Ann Plast Surg 69(4):347CrossRefPubMed
22.
go back to reference McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886–1892. doi:10.1097/PRS.0b013e31817151c4 CrossRefPubMed McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886–1892. doi:10.​1097/​PRS.​0b013e31817151c4​ CrossRefPubMed
25.
go back to reference Fischer JP, Sieber B, Nelson JA, Cleveland E, Kovach SJ, Wu LC, Kanchwala S, Serletti JM (2013) Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps. Plast Reconstr Surg 131(2):195–203. doi:10.1097/PRS.0b013e318277856f CrossRefPubMed Fischer JP, Sieber B, Nelson JA, Cleveland E, Kovach SJ, Wu LC, Kanchwala S, Serletti JM (2013) Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps. Plast Reconstr Surg 131(2):195–203. doi:10.​1097/​PRS.​0b013e318277856f​ CrossRefPubMed
26.
go back to reference Yan C, Fischer JP, Wes AM, Basta MN, Rohrbach JI, Kovach SJ, Serletti JM, Wu LC (2014) The cost of major complications associated with immediate two-stage expander/implant-based breast reconstruction. J Plast Surg Hand Surg 49(3):166–171. doi:10.3109/2000656X.2014.970639 CrossRefPubMed Yan C, Fischer JP, Wes AM, Basta MN, Rohrbach JI, Kovach SJ, Serletti JM, Wu LC (2014) The cost of major complications associated with immediate two-stage expander/implant-based breast reconstruction. J Plast Surg Hand Surg 49(3):166–171. doi:10.​3109/​2000656X.​2014.​970639 CrossRefPubMed
28.
go back to reference Kuczmarski RJ, Flegal KM (2000) Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72(5):1074–1081PubMed Kuczmarski RJ, Flegal KM (2000) Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72(5):1074–1081PubMed
29.
go back to reference Voineskos SH, Frank SG, Cordeiro PG (2015) Breast reconstruction following conservative mastectomies: predictors of complications and outcomes. Gland Surg 4(6):484–496PubMedPubMedCentral Voineskos SH, Frank SG, Cordeiro PG (2015) Breast reconstruction following conservative mastectomies: predictors of complications and outcomes. Gland Surg 4(6):484–496PubMedPubMedCentral
30.
35.
go back to reference Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Pierce LJ, Kronowitz SJ, Smith BD (2015) Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis. Ann Surg. doi:10.1097/sla.0000000000001177 PubMed Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Pierce LJ, Kronowitz SJ, Smith BD (2015) Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis. Ann Surg. doi:10.​1097/​sla.​0000000000001177​ PubMed
Metadata
Title
Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer
Authors
Jinhai Huo
Benjamin D. Smith
Sharon H. Giordano
Gregory P. Reece
Ya-Chen Tina Shih
Publication date
01-06-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3832-x

Other articles of this Issue 2/2016

Breast Cancer Research and Treatment 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine